Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/chapter/10.1007/978-3-319-20579-3_7.

Title:
Biobanking of Cerebrospinal Fluid for Biomarker Analysis in Neurological Diseases | SpringerLink
Description:
Cerebrospinal fluid (CSF) reflects pathophysiological aspects of neurological diseases, where neuroprotective strategies and biomarkers are urgently needed. Therefore, biobanking is very relevant for biomarker discovery and evaluation for these neurological diseases....
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Automotive
  • Science

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't tell how the site generates income.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {πŸ”}

pubmed, google, scholar, article, cas, cerebrospinal, fluid, csf, alzheimers, teunissen, clin, biobanking, preanalytical, central, chapter, biomarker, biomarkers, stability, disease, van, clinical, chem, analysis, storage, proteins, doi, neurol, human, research, international, blood, collection, springer, petzold, dis, amyloid, diseases, quality, deisenhammer, protein, tumani, proteome, factors, med, lewczuk, tau, lab, privacy, cookies, content,

Topics {βœ’οΈ}

month download article/chapter microplate-based kinetic assay carrier-mediated epitope masking request=ac03081400&find_code=wid high-resolution mass spectrometry maldi-tof mass spectrometry central nervous system pre-analytical quality indicators pre-analytical factors influencing post-lumbar puncture headaches pre-analytical quality control post-lumbar puncture headache springer international publishing privacy choices/manage cookies magnetic bead separation disease-specific csf investigations endogeneous peptide profiling van der flier device instant download amyloid-beta 42 adsorption amyloid beta peptides flight mass spectrometry amyloid Ξ² peptides post-lp headache van der voort de deyn pp cerebrospinal fluid proteins matrix metalloproteinase-2 concentrations soluble activation markers cerebrospinal fluid circulation cerebrospinal fluid abeta cerebrospinal fluid examined research lumbar puncture human cerebrospinal fluid acid sphingomyelinase activity brain specific proteins pre-analytical considerations cerebrospinal fluid collection enables biomarker studies cerebrospinal fluid markers cerebrospinal fluid biomarkers optimal control groups preanalytical factors affecting including sample collection european economic area humoral immune response healthy older volunteers intraindividual concomitant ventricular koel-simmelink van elk e

Questions {❓}

  • Carrette O, Burkhard PR, Hughes S, Hochstrasser DF, Sanchez J-C (2005) Truncated cystatin C in cerebrospiral fluid: technical [corrected] artefact or biological process?
  • Downer EJ, Campbell VA (2010) Phytocannabinoids, CNS cells and development: a dead issue?
  • Lomholt AF, Frederiksen CB, Christensen IJ, BrΓΌnner N, Nielsen HJ (2007) Plasma tissue inhibitor of metalloproteinases-1 as a biological marker?
  • At/ALEPH/-/F?

Schema {πŸ—ΊοΈ}

ScholarlyArticle:
      headline:Biobanking of Cerebrospinal Fluid for Biomarker Analysis in Neurological Diseases
      pageEnd:93
      pageStart:79
      image:https://media.springernature.com/w153/springer-static/cover/book/978-3-319-20579-3.jpg
      genre:
         Biomedical and Life Sciences
         Biomedical and Life Sciences (R0)
      isPartOf:
         name:Biobanking in the 21st Century
         isbn:
            978-3-319-20579-3
            978-3-319-20578-6
         type:Book
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Eline A. J. Willemse
            affiliation:
                  name:VU University Medical Center Amsterdam
                  address:
                     name:Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Charlotte E. Teunissen
            affiliation:
                  name:VU University Medical Center Amsterdam
                  address:
                     name:Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      keywords:Biobank, Cerebrospinal fluid, Neurology, Biomarkers, Quality control
      description:Cerebrospinal fluid (CSF) reflects pathophysiological aspects of neurological diseases, where neuroprotective strategies and biomarkers are urgently needed. Therefore, biobanking is very relevant for biomarker discovery and evaluation for these neurological diseases. An important aspect of CSF biobanking is quality control, needed for e.g. consistent patient follow-up and the exchange of patient samples between research centers. Systematic studies to address effects of pre-analytical and storage variation on a broad range of CSF proteins are needed and initiated. Important features of CSF biobanking are intensive collaboration in international networks and the tight application of standardized protocols. The current adoption of standardized protocols for CSF and blood collection and for biobanking of these samples, as presented in this chapter, enables biomarker studies in large cohorts of patients and controls. In conclusion, biomarker research in neurodegenerative diseases has entered a new era due to the collaborative and multicenter efforts of many groups. The streamlining of biobanking procedures, including sample collection, quality control, and the selection of optimal control groups for investigating biomarkers is an important improvement to perform high quality biomarker studies.
      datePublished:2015
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Biobanking in the 21st Century
      isbn:
         978-3-319-20579-3
         978-3-319-20578-6
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:VU University Medical Center Amsterdam
      address:
         name:Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
      name:VU University Medical Center Amsterdam
      address:
         name:Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Eline A. J. Willemse
      affiliation:
            name:VU University Medical Center Amsterdam
            address:
               name:Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Charlotte E. Teunissen
      affiliation:
            name:VU University Medical Center Amsterdam
            address:
               name:Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
      name:Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(313)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js

CDN Services {πŸ“¦}

  • Pbgrd

4.75s.